AHRP is a national network of lay people and professionals dedicated to advancing responsible and ethical medical research practices, to ensure that the human rights, dignity and welfare of human subjects are protected, and to minimize the risks associated with such endeavors.
 
Top News arrow News / Infomails arrow Death Following HPV vaccine
Death Following HPV vaccine Print E-mail
Monday, 12 November 2012
Another child casualty of a commercially-driven vaccination policy.

Dr. Lucija Tomjenovic, a post-doctoral biochemist at the University of British Columbia School of Medicine, presented an abstract at the International Conference on Pharmacovigilance and Clinical Trials held in Chicago (October, 2012). The abstract of a detailed scientific paper about to be published by the Open Access publication OMICS, describes the abnormal autoimmune response 14 days following vaccination with the quadrivalent human papillomavirus (HPV), which ultimately led to the death of a 15-year old girl.

In Spain, on October 9, 2012, Don Carlos Álvarez Dardet, Professor of Preventive Medicine and Public Health at the University of Alicante, and Dña Alicia Capilla Lanagrán, Vice President of the AAVP (the Association of those Affected by Papillomavirus Vaccines) held a press conference to explain the reasons behind requests by medical professionals urging a Moratorium on the use of HPV vaccines in Spain.
Indeed, in 2009, more than 10,000 health professionals and scientific associations signed a document entitled, “Reasons for a Moratorium on the use of HPV vaccines in Spain,” and submitted it to the Department of Health.
 
The AAVP  posted their demand for removal of HPV vaccines and the creation of a compensation fund for vaccine injury victims. Their website: www.nogracias.eu
See Rough English translation of Spain’s demand.
 

Read the illuminating detailed chapter by Mark Blaxill and Dan Olmsted analyzing the faulty basis for approval of the HPV vaccine in Vaccine Epidemic.

Vera Sharav

 

Death after quadrivalent human papillomavirus (qHPV) vaccination: Causal or coincidental?

By Lucija Tomljenovic, University of British Columbia, Canada

Presented at the International Conference on Pharmacovigilance and Clinical Trials, 1-3 October 2012

Herein reported is the case of a 15-year-old female without a relevant medical history, who developed severe headaches, speech problems, dizziness, weakness, inability to walk, depressed consciousness, confusion, amnesia and vomiting, 14 days after receiving her first qHPV vaccine injection. After the second vaccine booster, her symptoms worsened and she expired 15 days later. Autopsy revealed cerebral oedema and cerebellar herniation indicative of a focally disrupted blood-brain barrier.

There was no evidence of an active brain infection. Immunohistochemistry (IHC) examination of the brainstem, hippocampus and the cerebellum showed prominent infiltration of T-lymphocytes and macrophages in all brain areas examined. Notably, marked activation of the complement membrane attack complex (MAC) was detected in the cerebellar Purkinje cells, hippocampal neurons and portions of the brainstem. This pattern of MAC activation in the absence of an active brain infection indicates an abnormal triggering of the immune response in which the immune attack is directed towards self-tissue. Elevation of the pro-inflammatory IL-1 cytokine and intense micro- and astrogliosis were also evident in the patient’s brain. Altogether these observations strongly indicate that the acute neuronal damage resulting in patient’s death was due to an aberrant/excessive autoimmune and inflammatory response triggered by the vaccinations she received. Both the timing of the onset of symptoms as well as their nature, are consistent with previous case reports where causality between vaccination and the ensuing brain damage and/or death, was either demonstrated or strongly suspected. It thus appears that in some cases vaccination may be the triggering factor of fatal autoimmune/neurological events and physicians should be aware of this association.

Biography:

Lucija Tomljenovic holds a Ph.D in biochemistry and is currently a senior postdoctoral fellow at the University of British Columbia School of Medicine. Her current work focuses on neuroimmuno-toxic impacts of vaccine constituents, particularly aluminum adjuvants. She has published 7 papers in the last 12 months on the topic of vaccine safety in high-impact journals (JAMA, Annals of Medicine, Journal of Internal Medicine) and has recently presented her research as the invited speaker at the 8th International Congress on Autoimmunity in Granada. Tomljenovic serves as a peer reviewer for Vaccine, Journal of Inorganic Biochemistry, Lupus and Surgical Neurology International.

OMICS Publishing Group is an Open Access publication model that enables the ddissemination of research articles to the global community. Thus, all articles published under open access can be accessed by anyone.

 

 
< Prev   Next >
(C) 2014 Alliance for Human Research Protection

General Terms & Disclaimer:

This site is not a monologue of truth. It is a catalyst for public debate about medical research conduct. The reader is urged to confront officials to clarify issues mentioned herein. This site is designed strictly to provide information for critical, literary, academic an public usage. A qualified and trustworthy medical professional must be consulted regarding medical issues, treatments, diagnoses, etc.

Please read the General Terms and Conditions of this agreement entirely and carefully before accessing this web site. By accessing the site, you agree to be bound by the terms and conditions listed herein. [continue]